`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`PROLLENIUM US INC.,
`Petitioner,
`v.
`ALLERGAN INDUSTRIE, SAS,
`Patent Owner.
`_____________
`IPR2019-01505, Patent 8,450,475 B2
`IPR2019-01506, Patent 8,357,795 B2
`IPR2019-01508, Patent 9,238,013 B2
`IPR2019-01509, Patent 9,358,322 B2
`IPR2019-01617, Patent 8,822,676 B2
`IPR2019-01632, Patent 8,357,795 B2
`IPR2020-00084, Patent 9,089,519 B2
`_____________
`
`PATENT OWNER’S OBJECTIONS UNDER 37 C.F.R. § 42.64(b)(1)
`TO PETITIONER’S EVIDENCE1
`
`
`
`
`
`
`
`
`
`
`
`1 Authorization for the use of a joint caption page was received on April 27, 2020.
`Neither party opposes the use of a joint caption page. An identical paper has been
`filed in each case recited in the consolidated caption.
`
`
`
`IPR2019-01505, Patent 8,450,475 B2; IPR2019-01506, Patent 8,357,795 B2;
`IPR2019-01508, Patent 9,238,013 B2; IPR2019-01509, Patent 9,358,322 B2;
`IPR2019-01617, Patent 8,822,676 B2; IPR2019-01632, Patent 8,357,795 B2;
`IPR2020-00084, Patent 9,089,519 B2
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Patent Owner Allergan Industrie, SAS
`
`(“Patent Owner”) hereby submits these objections to Petitioner’s Declarations of
`
`Dr. Dale DeVore, numbered Exhibit 1002 in each of the above-captioned IPR
`
`proceedings.
`
`I.
`
`Exhibit 1002 Should Be Excluded Under Fed. R. Evid. 702
`Exhibit 1002 is improper expert testimony under Fed. R. Evid. 702 and
`
`should be excluded because Dr. DeVore is not a qualified expert under Daubert v.
`
`Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). Dr. DeVore’s cross-examination
`
`testimony revealed that he is not qualified in the pertinent art (see, e.g., IPR2019-
`
`01505, Exhibit 1002, ¶¶ 69-72), does not have a B.S., M.S., and Ph.D. in
`
`Biochemistry, did not base his testimony on sufficient facts and data, and his
`
`testimony is not the product of reliable principles and methods, all bases on which
`
`Exhibit 1002 should be excluded. Fed. R. Evid. 702(a), (b) and (c).
`
`II. Exhibit 1002 Should Be Excluded For Violating 37 C.F.R. § 42.11
`Exhibit 1002 should be excluded for the additional reason that its signatory,
`
`Dr. DeVore, misrepresented his credentials to the Board. See 37 C.F.R. § 42.11(b),
`
`(c). Dr. DeVore admitted during cross-examination that his Ph.D., M.S., and B.S.
`
`are in Food Science & Technology despite representing to the Board that his
`
`degrees were in Biochemistry.
`
`
`
`1
`
`
`
`IPR2019-01505, Patent 8,450,475 B2; IPR2019-01506, Patent 8,357,795 B2;
`IPR2019-01508, Patent 9,238,013 B2; IPR2019-01509, Patent 9,358,322 B2;
`IPR2019-01617, Patent 8,822,676 B2; IPR2019-01632, Patent 8,357,795 B2;
`IPR2020-00084, Patent 9,089,519 B2
`
`III. Patent Owner Objections to Exhibit 1002 Are Timely
`The objections made herein are based on testimony offered by Dr. DeVore at
`
`his recently concluded deposition. Dr. DeVore was deposed on August 12-14,
`
`2020. Patent Owner is filing these objections within five business days of the date
`
`on which Patent Owner was made aware of the relevant facts, which were
`
`discovered through cross-examining Dr. DeVore at his deposition. See 37 C.F.R.
`
`42.64(b)(1).
`
`
`
`
`
`
`
`
`
`Dated: August 19, 2020
`
`
`Respectfully Submitted,
`
`/Anthony M. Insogna/
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel.: (858) 314-1200
`Fax.: (844) 345-3178
`
`Attorney for Patent Owner
`
`2
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of Patent Owner’s Objections to
`
`Petitioner’s Evidence by electronic means at the following address of record:
`
`mcc.prollenium.ipr@mcciplaw.com
`
`Dated: August 19, 2020
`
`
`/Anthony M. Insogna/
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel.: (858) 314-1200
`Fax.: (844) 345-3178
`
`Attorney for Patent Owner
`
`
`
`
`
`
`
`